Search Results 261-270 of 14860 for alt

1. A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML) - Mayo Clinic

   Serum AST and/or alanine aminotransferase (ALT) < 3 x institutional upper limit of normal (ULN). Participant has left ventricular ejection fraction (LVEF) ...

2. A Study to Evaluate the Safety and Effectiveness of IFX-1 in Add-on to Standard of Care in Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - Mayo Clinic

   Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) > 5 x ULN. Acute or chronic liver disease. Known hypersensitivity to inactive ingredients ...

3. Treating Acute Pancreatitis with Dabigatran - Mayo Clinic

   Chronic ALT, AST, Alk Phos > 2 x ULN prior to hospitalization. Active hepatitis C, active hepatitis B, and active hepatitis A. Anemia (hemoglobin < 10 g/dL) ...

4. A Clinical Use Application for the Humanitarian Use Device Exemption Use Protocol of TheraSphere for Treatment of Unresectable Primary or Secondary Liver Neoplasia - Mayo Clinic

   AST or ALT >5 times UNL; For HCC: Serum bilirubin >2.0 mg/dl (unless segmental infusion is planned47); For other primary or secondary liver neoplasis ...

5. Itraconazole Therapy In Bronchiectasis With Airway Mold - Mayo Clinic

   Participation eligibility · Known diagnosis of allergic bronchopulmonary aspergillosis or invasive fungal disease. · Abnormal baseline liver function tests (ALT, ...

6. Study to Evaluate NBI-921352 as Adjunctive Therapy in Subjects With SCN8A Developmental and Epileptic Encephalopathy Syndrome (SCN8A-DEE) - Mayo Clinic

   ... (ALT, AST, and total bilirubin). Have ingested grapefruit juice or grapefruit products within a 7-day period before Day -1. Participating Mayo Clinic ...

7. A Safety Study of SGN-CD19A for Leukemia and Lymphoma - Mayo Clinic

   Baseline ALT and AST < 3 ULN. Exclusion Criteria: Allogeneic stem cell transplant within 60 days, active acute or chronic graft-versus-host disease (GvHD) ...

8. Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas - Mayo Clinic

   ... ALT ≤ 2.5 x ULN ; Alkaline phosphatase ≤2.5 x ULN; Negative Hepatitis B and Hepatitis C testing;; QTc interval ≤450ms. Exclusion Criteria: Radiation within ...

9. A Study of Intratumoral Injection of Autologous Dendritic Cells after High-Dose Conformal External Beam Radiotherapy in Patients with Unresectable Liver Cancer - Mayo Clinic

   Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤5 x ULN;; Creatinine ≤2 mg/dL;; PT/INR ≤1.5 x ULN. Negative pregnancy test done ≤7 ...

10. Study Evaluating ABT-199 in Subjects With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    AST and ALT ≤3 × upper limit of normal range (ULN);; Calculated creatinine clearance ≥30 mL/min using a modified Cockcroft-Gault calculation or a 24-hour ...